Cargando…

4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic

 : As COVID-19 cases started to rise in early 2020 and hospitalisation rates increased, health systems began to postpone non-emergency (elective) procedures to keep capacity available for COVID-19 patients, and to avoid elective patients being infected. This has subsequently led to longer waiting li...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593882/
http://dx.doi.org/10.1093/eurpub/ckac129.209
_version_ 1784815272954167296
collection PubMed
description  : As COVID-19 cases started to rise in early 2020 and hospitalisation rates increased, health systems began to postpone non-emergency (elective) procedures to keep capacity available for COVID-19 patients, and to avoid elective patients being infected. This has subsequently led to longer waiting lists and waiting times in virtually all countries. Issues around staff recruitment and retention, which have been exacerbated by the COVID-19 pandemic, have further aggravated the problem. For patients with common elective surgeries, such as hip and knee replacements, the backlog in care means that improvements in health and quality of life are postponed. For urgent care, such as missed chemotherapy sessions for cancer care, the delays can have more severe consequences. For other patients, the postponement of specialist appointments may lead to missed referrals for serious ailments. Increasingly also primary care has become affected leading to late diagnosis of chronic diseases, as well as inadequate follow up and control of these patients. Each delay in diagnosis and treatment may worsen health problems, prolong recovery and decrease the patients’ chances of survival. Countries are now left playing catch-up on these backlogs. There is however great uncertainty regarding the size of the backlogs, how much current and future capacity will be required to address them, and how much provider and workforce capacity will be needed for COVID-19 patients which will detract capacity for non-COVID patients. If health systems do not manage to reduce the backlog, they risk worsening health outcomes and wasting important health gains made in the last years. This workshop will discuss what we know about (1) the level of service disruptions and resulting backlog, (2) the drivers of backlog, and (3) which policies countries are using to address this. The workshop will conclude with an audience discussion about how to measure the true size of the backlog, the policy options for overcoming backlog and key priorities for further research. KEY MESSAGES: • The COVID-19 pandemic has led to substantial disruptions in care delivery leading to care backlogs in virtually all countries. • Countries have various policy options to tackle backlogs and bring down waiting times in the wake of the pandemic.
format Online
Article
Text
id pubmed-9593882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95938822022-11-04 4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic Eur J Public Health Parallel Programme  : As COVID-19 cases started to rise in early 2020 and hospitalisation rates increased, health systems began to postpone non-emergency (elective) procedures to keep capacity available for COVID-19 patients, and to avoid elective patients being infected. This has subsequently led to longer waiting lists and waiting times in virtually all countries. Issues around staff recruitment and retention, which have been exacerbated by the COVID-19 pandemic, have further aggravated the problem. For patients with common elective surgeries, such as hip and knee replacements, the backlog in care means that improvements in health and quality of life are postponed. For urgent care, such as missed chemotherapy sessions for cancer care, the delays can have more severe consequences. For other patients, the postponement of specialist appointments may lead to missed referrals for serious ailments. Increasingly also primary care has become affected leading to late diagnosis of chronic diseases, as well as inadequate follow up and control of these patients. Each delay in diagnosis and treatment may worsen health problems, prolong recovery and decrease the patients’ chances of survival. Countries are now left playing catch-up on these backlogs. There is however great uncertainty regarding the size of the backlogs, how much current and future capacity will be required to address them, and how much provider and workforce capacity will be needed for COVID-19 patients which will detract capacity for non-COVID patients. If health systems do not manage to reduce the backlog, they risk worsening health outcomes and wasting important health gains made in the last years. This workshop will discuss what we know about (1) the level of service disruptions and resulting backlog, (2) the drivers of backlog, and (3) which policies countries are using to address this. The workshop will conclude with an audience discussion about how to measure the true size of the backlog, the policy options for overcoming backlog and key priorities for further research. KEY MESSAGES: • The COVID-19 pandemic has led to substantial disruptions in care delivery leading to care backlogs in virtually all countries. • Countries have various policy options to tackle backlogs and bring down waiting times in the wake of the pandemic. Oxford University Press 2022-10-25 /pmc/articles/PMC9593882/ http://dx.doi.org/10.1093/eurpub/ckac129.209 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic
title 4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic
title_full 4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic
title_fullStr 4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic
title_full_unstemmed 4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic
title_short 4.B. Workshop: Addressing backlogs and managing waiting lists during and beyond the COVID-19 pandemic
title_sort 4.b. workshop: addressing backlogs and managing waiting lists during and beyond the covid-19 pandemic
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593882/
http://dx.doi.org/10.1093/eurpub/ckac129.209
work_keys_str_mv AT 4bworkshopaddressingbacklogsandmanagingwaitinglistsduringandbeyondthecovid19pandemic
AT 4bworkshopaddressingbacklogsandmanagingwaitinglistsduringandbeyondthecovid19pandemic